Biocept Inc (OTCPK:BIOCQ)
$ 0.0002 0 (0%) Market Cap: 1,000.00 Enterprise Value: 4.96 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2022 Biocept Inc Earnings Call Transcript

Nov 28, 2022 / 09:00PM GMT
Release Date Price: $23 (-3.46%)
Operator

Good day. And welcome to the Biocept third-quarter financial results conference call. (Operator Instructions) And please note that this event is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead.

Jody Cain
LHA - IR

This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from Biocept are Sam Riccitelli, Chairman and Interim President and Chief Executive Officer; and Antonino Morales, Interim Chief Financial Officer.

During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and generally can be identified by terms such as anticipates, estimates, believes, could, expects, intends, may, plans, potential, predicts, projects, should, will, would, or the negative of those terms.

Forward-looking statements involve known and unknown risks and uncertainties and other factors that may cause actual results,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot